{"id":"W2102718441","doi":"10.1634/theoncologist.2010-0307","title":"Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer","year":2011,"lang":"en","type":"article","venue":"The Oncologist","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":253,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"University of Texas MD Anderson Cancer Center; Merck KGaA","keywords":"Medicine; Keyhole limpet hemocyanin; Cyclophosphamide; Adjuvant; Metastatic breast cancer; Internal medicine; Breast cancer; Population; Seroconversion; Immunology; Cancer; Gastroenterology; Oncology; Chemotherapy; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001144137,0.0001443906,0.0002751382,0.00002139869,0.0001458976,0.00001435419,0.0005448858,0.000122572,0.0002265484],"category_scores_gemma":[0.0003923679,0.00007731902,0.0002696466,0.0001042854,0.0002597166,0.000004420971,0.0002145224,0.0001752344,0.00001007283],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002386518,"about_ca_system_score_gemma":0.0001910288,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003391838,"about_ca_topic_score_gemma":0.0004620966,"domain_scores_codex":[0.9984433,0.0003243744,0.0005029083,0.0002806219,0.0001761138,0.0002726617],"domain_scores_gemma":[0.9988534,0.0001015749,0.0002735399,0.0004991998,0.0001953555,0.00007691796],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4657739,0.01556044,0.00449765,0.0001733911,0.001413185,0.0000122167,0.0008138465,0.00009589807,0.3295066,0.0009314104,0.0532832,0.1279383],"study_design_scores_gemma":[0.4725222,0.01569602,0.009094536,0.00007196281,0.0006370337,0.00005936312,0.0008275042,0.002791893,0.3209096,0.000530109,0.1761417,0.0007181329],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938134,0.0001573217,0.0006889416,0.001729873,0.000469501,0.002014256,0.0002314187,0.00001012841,0.0008851867],"genre_scores_gemma":[0.9966688,0.0001298282,0.0003934989,0.0004675223,0.0004047235,0.0001764609,0.00003089956,0.00001893948,0.001709369],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1272202,"threshold_uncertainty_score":0.3152978,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1108185418277803,"score_gpt":0.4328358542687114,"score_spread":0.3220173124409311,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}